Can we optimize chemo-radiation and surgery in locally advanced stage III non-small cell lung cancer based on evidence from randomized clinical trials? A hypothesis-generating study-Reference-Cited by-同舟云学术

Can we optimize chemo-radiation and surgery in locally advanced stage III non-small cell lung cancer based on evidence from randomized clinical trials? A hypothesis-generating study

Published:2009-12 Issue:3 Volume:93 Page:389-395
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

De Ruysscher Dirk,Dehing Cary,Bentzen Søren M.,Houben Ruud,Dekker André,Wanders Rinus,Borger Jacques,Hochstenbag Monique,Boersma Liesbeth,Geskes Gijs,Dingemans Anne-Marie C.,Bootsma Gerben,Lammering Guido,Lambin Philippe

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference42 articles.

1. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials;Br Med J,1995

2. Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d’Oncologie Thoracique-Groupe Français de Pneumo-Cancérologie NPC 95-01 Study;Fournel;J Clin Oncol,2005

3. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer;Furuse;J Clin Oncol,1999

4. Long-term benefit is observed in a phase III comparison of sequential vs concurrent chemoradiation for patients with unresectable stage III nsclc: RTOG 94-10;Curran;Proc Am Soc Clin Oncol,2003

5. Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study;Zatloukal;Lung Cancer,2004

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 18F-FDG-PET guided vs whole tumour radiotherapy dose escalation in patients with locally advanced non-small cell lung cancer (PET-Boost): Results from a randomised clinical trial;Radiotherapy and Oncology;2023-04

2. Recent Developments and Challenges in Molecular-Targeted Therapy of Non-Small-Cell Lung Cancer;Journal of Environmental Pathology, Toxicology and Oncology;2023

3. A randomized phase II trial of concurrent chemoradiation with two doses of radiotherapy, 60 Gy and 66 Gy, concomitant with a fixed dose of oral vinorelbine in locally advanced NSCLC;Radiotherapy and Oncology;2017-05

4. Stage III Non-Small Cell Lung Cancer in the elderly: Patient characteristics predictive for tolerance and survival of chemoradiation in daily clinical practice;Radiotherapy and Oncology;2016-10

5. Pre-treatment non-target lung FDG-PET uptake predicts symptomatic radiation pneumonitis following Stereotactic Ablative Radiotherapy (SABR);Radiotherapy and Oncology;2016-06